Literature DB >> 29203475

HDL Particle Measurement: Comparison of 5 Methods.

Robert Matera1, Katalin V Horvath1,2, Hari Nair2, Ernst J Schaefer1,2, Bela F Asztalos3,2.   

Abstract

BACKGROUND: HDL cell cholesterol efflux capacity has been documented as superior to HDL cholesterol (HDL-C) in predicting cardiovascular disease risk. HDL functions relate to its composition. Compositional assays are easier to perform and standardize than functional tests and are more practical for routine testing. Our goal was to compare measurements of HDL particles by 5 different separation methods.
METHODS: HDL subfractions were measured in 98 samples using vertical auto profiling (VAP), ion mobility (IM), nuclear magnetic resonance (NMR), native 2-dimensional gel electrophoresis (2D-PAGE), and pre-β1-ELISA. VAP measured cholesterol in large HDL2 and small HDL3; IM measured particle number directly in large, intermediate, and small HDL particles; NMR measured lipid signals in large, medium, and small HDL; 2D-PAGE measured apolipoprotein (apo) A-I in large (α1), medium (α2), small (α3-4), and pre-β1 HDL particles; and ELISA measured apoA-I in pre-β1-HDL. The data were normalized and compared using Passing-Bablok, Lin concordance, and Bland-Altman plot analyses.
RESULTS: With decreasing HDL-C concentration, NMR measured a gradually lower percentage of large HDL, compared with IM, VAP, and 2D-PAGE. In the lowest HDL-C tertile, NMR measured 8% of large HDL, compared with IM, 22%; VAP, 20%; and 2D-PAGE, 18%. There was strong discordance between 2D-PAGE and NMR in measuring medium HDL (R2 = 0.356; rc = 0.042) and small HDL (R2 = 0.376; rc = 0.040). The 2D-PAGE assay measured a significantly higher apoA-I concentration in pre-β1-HDL than the pre-β1-ELISA (9.8 vs 1.6 mg/dL; R2 = 0.246; rc = 0.130).
CONCLUSIONS: NMR agreed poorly with the other methods in measuring large HDL, particularly in low HDL-C individuals. Similarly, there was strong discordance in pre-β1-HDL measurements between the ELISA and 2D-PAGE assays.
© 2017 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29203475     DOI: 10.1373/clinchem.2017.277632

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease.

Authors:  Anna Gliwińska; Agnieszka Ćwiklińska; Monika Czaplińska; Ewa Wieczorek-Breitzke; Barbara Kortas-Stempak; Agnieszka Kuchta; Alicja Dębska-Ślizień; Ewa Król; Maciej Jankowski
Journal:  J Nephrol       Date:  2022-08-09       Impact factor: 4.393

2.  Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations.

Authors:  Martin Rief; Reinhard Raggam; Peter Rief; Philipp Metnitz; Tatjana Stojakovic; Markus Reinthaler; Marianne Brodmann; Winfried März; Hubert Scharnagl; Günther Silbernagel
Journal:  Biomedicines       Date:  2022-07-21

3.  Greater IL-6, D-dimer, and ICAM-1 Levels Are Associated With Lower Small HDL Particle Concentration in the Multicenter AIDS Cohort Study.

Authors:  Sudipa Sarkar; Sabina Haberlen; Seamus Whelton; Edward E Schneider; Lawrence Kingsley; Frank Palella; Mallory D Witt; Theodoros Kelesidis; Annabelle Rodriguez; Wendy S Post; Todd T Brown
Journal:  Open Forum Infect Dis       Date:  2019-11-13       Impact factor: 4.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.